Evidence map›Paper›PMID 36712672›Full record

ArticleFrontiers in pharmacology2022

HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer.

Rui Jiang, Jinghua Wang, Jun Liang, Daihua Lin, Qiuxian Mao, Siyi Cheng, Shengjun Huang, Shuangshuang Tong, Yanlin Lyu, Rui Wei and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rui JiangDepartment of Gastroenterology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Jinghua WangDepartment of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Jun LiangDepartment of Critical Care Medicine, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Daihua LinPrenatal Diagnostic Center, Guangdong Second Provincial General Hospital, Guangzhou, China.
Qiuxian MaoPrenatal Diagnostic Center, Guangdong Second Provincial General Hospital, Guangzhou, China.
Siyi ChengSchool of Bioscience and Bioengineering, South China University of Technology, Guangzhou, China.
Shengjun HuangSchool of Medicine, South China University of Technologyy, Guangzhou, China.
Shuangshuang TongShantou University Medical College, Shantou, China.
Yanlin LyuShantou University Medical College, Shantou, China.
Rui WeiDepartment of Gastroenterology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Qizhou LianFaculty of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Hao ChenDepartment of Gastroenterology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

drug sensitivity analysisgastric cancerhippo signaling pathwayprognostic predictiontherapeutic response

Identifiers

PMID36712672
PMCPMC9873967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.